0.0131
+0.0001
+(0.77%)
At close: January 31 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-10,672.0000
-7,725.0000
-2,266.0000
-2,151.0000
Investing Cash Flow
369.0000
725.0000
-183.0000
--
Financing Cash Flow
1,443.0000
10,929.0000
2,448.0000
1,898.0000
End Cash Position
-216.0000
4,228.0000
--
--
Interest Paid Supplemental Data
204.0000
124.0000
--
--
Issuance of Capital Stock
--
--
1,341.0000
1,210.0000
Issuance of Debt
1,132.0000
2,286.0000
1,107.0000
688.0000
Free Cash Flow
-10,723.0000
-7,725.0000
-2,266.0000
-2,151.0000
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NLSPW NLS Pharmaceutics AG
0.0162
+32.79%
DRMAW Dermata Therapeutics, Inc.
0.0297
0.00%
ATNFW 180 Life Sciences Corp.
0.0180
+125.00%
KMSTF Kadimastem Ltd
0.6404
-90.00%
APLIF Appili Therapeutics Inc.
0.0230
0.00%
CEROW CERo Therapeutics Holdings, Inc.
0.0179
+18.54%
CELUW Celularity Inc.
0.0699
+5.91%
LIXTW Lixte Biotechnology Holdings, Inc.
0.0280
+32.70%
APLMW Apollomics, Inc.
0.0088
-20.00%
PTIXW Protagenic Therapeutics, Inc.
0.0040
0.00%